David H. Bollinger

Array ( [id] => 4213652 [patent_doc_number] => 06087122 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-11 [patent_title] => 'Human E3 ubiquitin protein ligase' [patent_app_type] => 1 [patent_app_number] => 9/357746 [patent_app_country] => US [patent_app_date] => 1999-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 21416 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/087/06087122.pdf [firstpage_image] =>[orig_patent_app_number] => 357746 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4129393 [patent_doc_number] => 06033910 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-07 [patent_title] => 'Antisense inhibition of MAP kinase kinase 6 expression' [patent_app_type] => 1 [patent_app_number] => 9/357073 [patent_app_country] => US [patent_app_date] => 1999-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26514 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/033/06033910.pdf [firstpage_image] =>[orig_patent_app_number] => 357073 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4250610 [patent_doc_number] => 06136965 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-24 [patent_title] => 'Deoxynucleic alkyl and alkoxy thiourea compounds' [patent_app_type] => 1 [patent_app_number] => 9/347443 [patent_app_country] => US [patent_app_date] => 1999-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 20 [patent_no_of_words] => 11983 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/136/06136965.pdf [firstpage_image] =>[orig_patent_app_number] => 347443 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4171412 [patent_doc_number] => 06083727 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-04 [patent_title] => 'Methods and compositions for producing 5\' enriched cDNA libraries' [patent_app_type] => 1 [patent_app_number] => 9/343945 [patent_app_country] => US [patent_app_date] => 1999-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5418 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 177 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/083/06083727.pdf [firstpage_image] =>[orig_patent_app_number] => 343945 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4212528 [patent_doc_number] => 06110664 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-29 [patent_title] => 'Antisense inhibition of G-alpha-S1 expression' [patent_app_type] => 1 [patent_app_number] => 9/344914 [patent_app_country] => US [patent_app_date] => 1999-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27838 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/110/06110664.pdf [firstpage_image] =>[orig_patent_app_number] => 344914 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4080246 [patent_doc_number] => 06054316 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-25 [patent_title] => 'Antisense inhibition of ETs-2 expression' [patent_app_type] => 1 [patent_app_number] => 9/344579 [patent_app_country] => US [patent_app_date] => 1999-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25975 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/054/06054316.pdf [firstpage_image] =>[orig_patent_app_number] => 344579 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4082102 [patent_doc_number] => 06054440 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-25 [patent_title] => 'Antisense inhibition of Jun N-terminal Kinase Kinase-2 expression' [patent_app_type] => 1 [patent_app_number] => 9/344001 [patent_app_country] => US [patent_app_date] => 1999-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26016 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/054/06054440.pdf [firstpage_image] =>[orig_patent_app_number] => 344001 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1516908 [patent_doc_number] => 06500615 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-31 [patent_title] => 'Identifying antisense oligonucleotide binding' [patent_app_type] => B1 [patent_app_number] => 09/269555 [patent_app_country] => US [patent_app_date] => 1999-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 13 [patent_no_of_words] => 5978 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 199 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/500/06500615.pdf [firstpage_image] =>[orig_patent_app_number] => 09269555 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6674831 [patent_doc_number] => 20030060434 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-27 [patent_title] => 'COMBINED TUMOR SUPPRESSOR GENE THERAPY AND CHEMOTHERAPY IN THE TREATMENT OF NEOPLASMS' [patent_app_type] => new [patent_app_number] => 09/311772 [patent_app_country] => US [patent_app_date] => 1999-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 33549 [patent_no_of_claims] => 77 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0060/20030060434.pdf [firstpage_image] =>[orig_patent_app_number] => 09311772 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 941372 [patent_doc_number] => 06969763 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-11-29 [patent_title] => 'Molecular interaction sites of interleukin-2 RNA and methods of modulating the same' [patent_app_type] => utility [patent_app_number] => 09/310844 [patent_app_country] => US [patent_app_date] => 1999-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 88 [patent_figures_cnt] => 89 [patent_no_of_words] => 72533 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/969/06969763.pdf [firstpage_image] =>[orig_patent_app_number] => 09310844 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1599748 [patent_doc_number] => 06475724 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-05 [patent_title] => 'Nucleic acids, kits, and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders' [patent_app_type] => B1 [patent_app_number] => 09/306828 [patent_app_country] => US [patent_app_date] => 1999-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 34367 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/475/06475724.pdf [firstpage_image] =>[orig_patent_app_number] => 09306828 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4356048 [patent_doc_number] => 06200956 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-13 [patent_title] => 'Nucleic acid-containing composition, preparation and use thereof' [patent_app_type] => 1 [patent_app_number] => 9/306044 [patent_app_country] => US [patent_app_date] => 1999-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9805 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/200/06200956.pdf [firstpage_image] =>[orig_patent_app_number] => 306044 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4335032 [patent_doc_number] => 06333148 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-25 [patent_title] => 'Genes encoding several poly (ADP-ribose) glycohydrolase (PARG) enzymes, the proteins and fragments thereof, and antibodies immunoreactive therewith' [patent_app_type] => 1 [patent_app_number] => 9/302812 [patent_app_country] => US [patent_app_date] => 1999-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 37033 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/333/06333148.pdf [firstpage_image] =>[orig_patent_app_number] => 302812 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1490612 [patent_doc_number] => 06417169 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-09 [patent_title] => 'Insulin-like growth factor II antisense oligonucleotide sequences and methods of using same to inhibit cell growth' [patent_app_type] => B1 [patent_app_number] => 09/295593 [patent_app_country] => US [patent_app_date] => 1999-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 19 [patent_no_of_words] => 13877 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/417/06417169.pdf [firstpage_image] =>[orig_patent_app_number] => 09295593 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4257258 [patent_doc_number] => 06204055 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-20 [patent_title] => 'Antisense inhibition of Fas mediated signaling' [patent_app_type] => 1 [patent_app_number] => 9/290640 [patent_app_country] => US [patent_app_date] => 1999-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17396 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/204/06204055.pdf [firstpage_image] =>[orig_patent_app_number] => 290640 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4407487 [patent_doc_number] => 06300131 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-09 [patent_title] => 'Telomerase-associated proteins' [patent_app_type] => 1 [patent_app_number] => 9/286959 [patent_app_country] => US [patent_app_date] => 1999-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 13 [patent_no_of_words] => 11587 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/300/06300131.pdf [firstpage_image] =>[orig_patent_app_number] => 286959 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4293182 [patent_doc_number] => 06184034 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-06 [patent_title] => 'Deoxyribonuclease II proteins and cDNAS' [patent_app_type] => 1 [patent_app_number] => 9/147915 [patent_app_country] => US [patent_app_date] => 1999-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4234 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/184/06184034.pdf [firstpage_image] =>[orig_patent_app_number] => 147915 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6082385 [patent_doc_number] => 20020082225 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-27 [patent_title] => 'ENZYMATIC NUCLEIC ACID TREATMENT OF DISEASES OR CONDITIONS RELATED TO HEPATITIS C VIRUS INFECTION' [patent_app_type] => new [patent_app_number] => 09/274553 [patent_app_country] => US [patent_app_date] => 1999-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 36498 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20020082225.pdf [firstpage_image] =>[orig_patent_app_number] => 09274553 [rel_patent_id] =>[rel_patent_doc_number] =>)